Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

From Structure to Function and Back Again: A GAN-Guided Diffusion Framework for Generating Clinically Meaningful Multimodal Neuroimaging Data.

Research square·2026
Same author

Features predicting data exclusion in imaging studies of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Plasma Proteomic Networks Reveal Shared Biology with Brain Linked to Alzheimer's Disease Pathology.

medRxiv : the preprint server for health sciences·2026
Same author

Differential DNA methylation in blood as potential mediator of the association between ambient PM<sub>2.5</sub> and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort.

Molecular psychiatry·2026
Same author

Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Highly Accelerated 1-mm Isotropic 3D Chemical Exchange Saturation Transfer MRI Using Wave-Co-CAIPI at 5 Tesla.

IEEE transactions on bio-medical engineering·2026
Same journal

Systematic Evaluation of Hip Exoskeleton Assistance Parameters for Enhancing Gait Stability During Ground Slip Perturbations.

IEEE transactions on bio-medical engineering·2026
Same journal

SleepConFormer: A Single-Channel EEG Framework for Sleep Staging and Consciousness Assessment in Patients with Disorders of Consciousness.

IEEE transactions on bio-medical engineering·2026
Same journal

Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework.

IEEE transactions on bio-medical engineering·2026
Same journal

A Low-Cost Wearable TI-TACS Stimulator With Bipolar Quadratic-Boost Converter for Current Stimulation Validation in the Rat Brain.

IEEE transactions on bio-medical engineering·2026
Same journal

EMG-Based Gait Estimation Using Koopman-Inspired Method.

IEEE transactions on bio-medical engineering·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

350

From Symptomatic to Pre-Symptomatic: Adaptive Knowledge Distillation for Early Alzheimer's Detection Using Functional

Yuxiang Wei, Anees Abrol, James Lah

    IEEE Transactions on Bio-Medical Engineering
    |August 20, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Early Alzheimer's disease (AD) detection is crucial. Our novel framework uses knowledge distillation and Unbalanced Optimal Transport to improve functional magnetic resonance imaging (fMRI) analysis for identifying pre-symptomatic AD, even with imbalanced data.

    More Related Videos

    Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.3K
    A Free-breathing fMRI Method to Study Human Olfactory Function
    10:42

    A Free-breathing fMRI Method to Study Human Olfactory Function

    Published on: July 30, 2017

    9.7K

    Related Experiment Videos

    Last Updated: Sep 10, 2025

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
    05:17

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

    Published on: April 18, 2025

    350
    Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.3K
    A Free-breathing fMRI Method to Study Human Olfactory Function
    10:42

    A Free-breathing fMRI Method to Study Human Olfactory Function

    Published on: July 30, 2017

    9.7K

    Area of Science:

    • Neuroscience
    • Medical Imaging
    • Artificial Intelligence

    Background:

    • Alzheimer's disease (AD) diagnosis requires early detection for timely intervention.
    • Functional magnetic resonance imaging (fMRI) shows promise for non-invasive AD biomarkers.
    • Current fMRI methods struggle with pre-symptomatic AD detection due to subtle patterns and severe class imbalance.

    Purpose of the Study:

    • To develop a novel framework for reliable pre-symptomatic Alzheimer's disease detection using fMRI.
    • To address challenges of subtle anatomical differences and class imbalance in early AD detection.
    • To improve diagnostic accuracy by leveraging knowledge distillation from symptomatic to pre-symptomatic stages.

    Main Methods:

    • Proposed a margin-aware knowledge distillation (KD) framework for multi-stage AD diagnosis.
    • Utilized Unbalanced Optimal Transport (UOT) for feature distillation to adapt to neurodegeneration-induced anatomical changes.
    • Implemented Self-Distillation with Dynamic Margins to mitigate class imbalance issues.

    Main Results:

    • Demonstrated the superiority of the proposed KD framework over state-of-the-art methods across four base models.
    • Successfully identified significant brain regions involved in pre-symptomatic AD detection.
    • Showcased effective feature transfer during the distillation process.

    Conclusions:

    • The novel KD framework significantly advances early Alzheimer's disease diagnosis capabilities.
    • The approach offers more precise diagnostic tools by understanding early disease manifestations.
    • This work represents a significant stride towards reliable and earlier Alzheimer's disease detection.